TENEOBIO INC has a total of 110 patent applications. It decreased the IP activity by 2.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and agriculture are Numab Therapeutics AG, LAZAR GREGORY ALAN and ULTRAHUMAN EIGHT LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 13 | |
#2 | Australia | 11 | |
#3 | Canada | 11 | |
#4 | Brazil | 9 | |
#5 | Republic of Korea | 9 | |
#6 | China | 8 | |
#7 | EPO (European Patent Office) | 8 | |
#8 | Israel | 8 | |
#9 | United States | 7 | |
#10 | Singapore | 6 | |
#11 | Mexico | 4 | |
#12 | Chile | 2 | |
#13 | Colombia | 2 | |
#14 | Costa Rica | 2 | |
#15 | Ecuador | 2 | |
#16 | Peru | 2 | |
#17 | Philippines | 2 | |
#18 | Dominican Republic | 1 | |
#19 | Jordan | 1 | |
#20 | Nicaragua | 1 | |
#21 | Uruguay | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Agriculture |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Trinklein Nathan | 67 |
#2 | Aldred Shelley Force | 62 |
#3 | Van Schooten Wim | 60 |
#4 | Harris Katherine | 47 |
#5 | Rangaswamy Udaya | 22 |
#6 | Pham Duy | 21 |
#7 | Dang Kevin | 18 |
#8 | Trinklein Nathan D | 15 |
#9 | Ogana Heather Anne N | 14 |
#10 | Vanschooten Wim | 14 |
Publication | Filing date | Title |
---|---|---|
US2021047402A1 | Multispecific heavy chain antibodies binding to cd22 and cd3 | |
WO2020206330A1 | Heavy chain antibodies binding to psma | |
WO2020087065A1 | Heavy chain antibodies binding to cd38 | |
CA3113057A1 | Methods for purifying heterodimeric, multispecific antibodies | |
BR112020024074A2 | heavy chain antibodies with cd19 binding | |
SG11202006042SA | Cd3-delta/epsilon heterodimer specific antibodies | |
CR20200322A | Heavy chain antibodies binding to cd22 | |
AU2018331421A1 | Heavy chain antibodies binding to ectoenzymes | |
EP3642237A2 | Anti-bcma heavy chain-only antibodies | |
MX2019007379A | Anti-bcma heavy chain-only antibodies. | |
KR20190052006A | Transgenic non-human animal producing a modified heavy-chain antibody | |
CN109641049A | CD3 binding antibody | |
AU2017327723A1 | CD3 binding antibodies |